I agree that this site is using cookies. You can find further informations here.
X
Pierga, J.Y.
146  results:
Search for persons X
?
1

Alpelisib and fulvestrant in PIK3CA-mutated hormone recepto..:

Bello Roufai, D. ; Gonçalves, A. ; De La Motte Rouge, T....
Oncogene.  , 2023
Link: https://doi.org/10.1038/..
 
?
2

Correction: Alpelisib and fulvestrant in PIK3CA-mutated hor..:

Bello Roufai, D. ; Gonçalves, A. ; De La Motte Rouge, T....
Oncogene.  42 (2023)  17 - p. 1417-1417 , 2023
Link: https://doi.org/10.1038/..
 
?
3

Concurrent Olaparib with Radiotherapy in Patients with Trip..:

Loap, P. ; Loirat, D. ; Berger, F....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. S43-S44 , 2022
Link: https://doi.org/10.1016/..
 
?
4

A Therapeutic Challenge: Chemo-refractory Non-metastatic In..:

Loap, P. ; Nicaise, B. ; Laki, F....
Clinical Oncology.  34 (2022)  3 - p. e140 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Population pharmacokinetics and exposure–response relations..:

Petitcollin, A. ; Azzopardi, N. ; Pierga, J. Y....
European Journal of Clinical Pharmacology.  77 (2021)  12 - p. 1861-1873 , 2021
Link: https://doi.org/10.1007/..
 
?
6

One-Year Toxicity Report of the RADIOPARP Phase I Trial Eva..:

Loap, P. ; Loirat, D. ; Berger, F....
International Journal of Radiation Oncology*Biology*Physics.  111 (2021)  3 - p. S8 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Clinical utility of MammaPrint testing in Invasive Lobular ..:

Metzger, O. ; Cardoso, F. ; Poncet, C....
European Journal of Cancer.  138 (2020)  - p. S5-S6 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Updated results of the MINDACT trial: 70-gene signature to ..:

Rutgers, E.J.T. ; van 't Veer, L. ; Poncet, C....
European Journal of Cancer.  138 (2020)  - p. S14-S15 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Long-term survival in HER2-positive metastatic breast cance..:

Kaczmarek, E. ; Saint-Martin, C. ; Pierga, J.-Y....
Breast Cancer Research and Treatment.  178 (2019)  3 - p. 505-512 , 2019
Link: https://doi.org/10.1007/..
 
?
10

PO-497 Microtubule regulatory proteins as predictive biomar..:

Moindjie, H. ; Rodrigues-Ferreira, S. ; Dujaric, M.E....
ESMO Open.  3 (2018)  - p. A216-A217 , 2018
Link: https://doi.org/10.1136/..
 
?
11

OC-0159: Disseminated tumor cells as factor of benefit of r..:

Mignot, F. ; Bidard, F.C. ; Dureau, S....
Radiotherapy and Oncology.  127 (2018)  - p. S81 , 2018
Link: https://doi.org/10.1016/..
 
?
12

5-years relapse-free survival and predictive factors identi..:

Lerebours, F. ; Pulido, M. ; Fourme, E....
European Journal of Cancer.  92 (2018)  - p. S19 , 2018
Link: https://doi.org/10.1016/..
 
?
13

A gene signature to predict high tumor-infiltrating lymphoc..:

Criscitiello, C. ; Bayar, M.A. ; Curigliano, G....
Annals of Oncology.  29 (2018)  1 - p. 162-169 , 2018
Link: https://doi.org/10.1093/..
 
?
14

Trasutuzumab versus observation for high-risk, non-metastat..:

Ignatiadis, M. ; Litiere, S. ; Rothe, F....
European Journal of Cancer.  92 (2018)  - p. S7 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Circulating tumor cell count and thrombosis in metastatic b..:

Beinse, G. ; Berger, F. ; Cottu, P....
Journal of Thrombosis and Haemostasis.  15 (2017)  10 - p. 1981-1988 , 2017
Link: https://doi.org/10.1111/..
 
1-15